Defect in fatty acid esterification of dolichol in Niemann-Pick type C1 mouse livers in vivo.
Fatty acid esterification of dolichol and cholesterol in Niemann-Pick type C1 mouse (Balb/c NIH npc1(-/-)) livers was investigated in response to treatment with peroxisomal proliferators. These inducers have hypolipidemic properties and influence the mevalonate pathway and the intracellular transport of the final products of this biosynthetic route. Such inducers are consequently interesting to use in a disease model with defective intracellular transport of lipids. In wild-type mice, the levels of dolichol and cholesterol found as free alcohols were not changed to any great extent upon treatment with the peroxisomal inducers dehydroepiandrosterone, clofibrate and diethylhexylphtalate. In contrast, the amounts of dolichyl esters increased whereas cholesteryl esters decreased by the same treatments. The rate of enzymatic esterification of dolichol in isolated microsomes was accordingly elevated after 5- to 7-day treatments with the efficient peroxisomal proliferators DEHP and PFOA, while the corresponding esterification of cholesterol was decreased. Upon peroxisomal induction in npc1(-/-) mice, the enzymatic dolichol esterification in vitro increased whereas the low concentration of dolichyl esters remained unchanged. The results thus demonstrate that the induction of fatty acid esterification of dolichol in vivo is impaired in npc1(-/-) mouse liver. It is therefore proposed that the intracellular lipid transport defect in npc1(-/-) mouse liver disables either dolichol and/or the fatty acid from reaching the site of esterification in vivo. This proposal was strengthened by the finding that the amount of dolichol was decreased in an isolated Golgi fraction from npc1(-/-) mice.
Turunen
Mikael
M
Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Schedin-Weiss
Sophia
S
D000217:Acyltransferases / Q000378:metabolism; D000818:Animals; D002417:Cattle; D002788:Cholesterol Esters / Q000032:analysis; D002851:Chromatography, High Pressure Liquid; D004286:Dolichols / Q000378:metabolism*; D004951:Esterification / Q000187:drug effects; D005227:Fatty Acids / Q000378:metabolism*; D047908:Intracellular Signaling Peptides and Proteins; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008110:Liver Extracts; D051379:Mice; D008807:Mice, Inbred BALB C; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D009154:Mutation / Q000235:genetics; D000077296:Niemann-Pick C1 Protein; D052556:Niemann-Pick Disease, Type C / Q000378:metabolism*; D020025:Peroxisome Proliferators / Q000494:pharmacology; D011506:Proteins / Q000235:genetics / Q000378:metabolism; D002785:Sterol O-Acyltransferase / Q000378:metabolism; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism
D002788:Cholesterol Esters; D004286:Dolichols; D005227:Fatty Acids; D047908:Intracellular Signaling Peptides and Proteins; D008110:Liver Extracts; D000077296:Niemann-Pick C1 Protein; C106831:Npc1 protein, mouse; D020025:Peroxisome Proliferators; D011506:Proteins; D000217:Acyltransferases; C077400:phosphatidylethanolamine - dolichol acyltransferase; D002785:Sterol O-Acyltransferase